196 related articles for article (PubMed ID: 3524050)
1. Study of live recombinant cold-adapted influenza bivalent vaccine of type A for use in children: an epidemiological control trial.
Alexandrova GI; Budilovsky GN; Koval TA; Polezhaev FI; Garmashova LM; Ghendon YuZ ; Romanova YR; Smorodintsev AA
Vaccine; 1986 Jun; 4(2):114-8. PubMed ID: 3524050
[TBL] [Abstract][Full Text] [Related]
2. [Cold-adapted strain of A/Leningrad/134/47/57 (H2N2)--a special attenuation donor of live influenza vaccine for children and the isolation of its recombinants].
Garmashova LM; Polezhaev FI; Aleksandrova GI
Vopr Virusol; 1984; 29(1):28-31. PubMed ID: 6710978
[TBL] [Abstract][Full Text] [Related]
3. [Safety and high immunogenicity for children 3 to 15 of a mono- and a divaccine from recombinant influenza A/Brazil /11/78 (H1N1) and A/Bangkok/1/79 (H3N2) viruses obtained from a special donor attenuation base--the cold-adapted virus A/Leningrad/134/47/57 (H2N2)].
Polezhaev FI; Budilovskiĭ GN; Garmashova LM; Romeĭko-Gurko IuR; Egorov AIu
Vopr Virusol; 1983; 28(6):710-4. PubMed ID: 6670253
[TBL] [Abstract][Full Text] [Related]
4. Recombinant cold-adapted attenuated influenza A vaccines for use in children: reactogenicity and antigenic activity of cold-adapted recombinants and analysis of isolates from the vaccinees.
Alexandrova GI; Polezhaev FI; Budilovsky GN; Garmashova LM; Topuria NA; Egorov AY; Romejko-Gurko YR; Koval TA; Lisovskaya KV; Klimov AI
Infect Immun; 1984 Jun; 44(3):734-9. PubMed ID: 6724695
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children.
Belshe RB; Mendelman PM; Treanor J; King J; Gruber WC; Piedra P; Bernstein DI; Hayden FG; Kotloff K; Zangwill K; Iacuzio D; Wolff M
N Engl J Med; 1998 May; 338(20):1405-12. PubMed ID: 9580647
[TBL] [Abstract][Full Text] [Related]
6. Clinical and epidemiological evaluation of a live, cold-adapted influenza vaccine for 3-14-year-olds.
Rudenko LG; Lonskaya NI; Klimov AI; Vasilieva RI; Ramirez A
Bull World Health Organ; 1996; 74(1):77-84. PubMed ID: 8653819
[TBL] [Abstract][Full Text] [Related]
7. Immunization of institutionalized asthmatic children and patients with psychomotor retardation using live attenuated cold-adapted reassortment influenza A H1N1, H3N2 and B vaccines.
Miyazaki C; Nakayama M; Tanaka Y; Kusuhara K; Okada K; Tokugawa K; Ueda K; Shibata R; Nishima S; Yamane N
Vaccine; 1993; 11(8):853-8. PubMed ID: 8356846
[TBL] [Abstract][Full Text] [Related]
8. In vitro production of anti-influenza virus antibody after simultaneous administration of H3N2 and H1N1 cold-adapted vaccines in seronegative children.
Edwards KM; Snyder P; Thompson JM; Johnson PR; Wright PF
Vaccine; 1986 Mar; 4(1):50-4. PubMed ID: 3962451
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of live attenuated influenza vaccines in children 6-18 months of age: safety, immunogenicity, and efficacy. National Institute of Allergy and Infectious Diseases, Vaccine and Treatment Evaluation Program and the Wyeth-Ayerst ca Influenza Vaccine Investigators Group.
Gruber WC; Belshe RB; King JC; Treanor JJ; Piedra PA; Wright PF; Reed GW; Anderson E; Newman F
J Infect Dis; 1996 Jun; 173(6):1313-9. PubMed ID: 8648202
[TBL] [Abstract][Full Text] [Related]
10. Use of influenza A virus vaccines in seronegative children: live cold-adapted versus inactivated whole virus.
Feldman S; Wright PF; Webster RG; Roberson PK; Mahoney J; Thompson J; Doolittle M; Lott L; Johnson P; Christoph RC
J Infect Dis; 1985 Dec; 152(6):1212-8. PubMed ID: 3905983
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of bivalent live attenuated influenza A vaccines in children 2 months to 3 years of age: safety, immunogenicity and dose-response.
Gruber WC; Darden PM; Still JG; Lohr J; Reed G; Wright PF
Vaccine; 1997; 15(12-13):1379-84. PubMed ID: 9302748
[TBL] [Abstract][Full Text] [Related]
12. Attenuated ts-recombinants of influenza A/USSR/77 (H1N1) virus obtained by crossing with the cold-adapted donor A/Leningrad/134/57 (H2N2) virus.
Polezhaev FI; Garmashova LM; Koval TA; Taranova GP; Topuriya NV; Aleksandrova GI
Acta Virol; 1982 Jul; 26(4):221-6. PubMed ID: 6127928
[TBL] [Abstract][Full Text] [Related]
13. Cold-adapted recombinant influenza A virus vaccines in seronegative young children.
Wright PF; Okabe N; McKee KT; Maassab HF; Karzon DT
J Infect Dis; 1982 Jul; 146(1):71-9. PubMed ID: 7045254
[TBL] [Abstract][Full Text] [Related]
14. Studies on reactogenicity and immunogenicity of attenuated bivalent cold recombinant influenza type A (CRA) and inactivated trivalent influenza virus (TI) vaccines in infants and young children.
Piedra PA; Glezen WP; Mbawuike I; Gruber WC; Baxter BD; Boland FJ; Byrd RW; Fan LL; Lewis JK; Rhodes LJ
Vaccine; 1993; 11(7):718-24. PubMed ID: 8342319
[TBL] [Abstract][Full Text] [Related]
15. Class-specific antibody responses in school children vaccinated with an A/Brazil/11/78 (H1N1)-like recombinant influenza virus prepared from the A/Leningrad/134/57 paediatric cold-adapted donor strain.
Slepushkin AN; Patriarca PA; Obrosova-Serova NP; Harmon MW; Kupryashina LN; Cheshik SG; Vartanyan RB; Alexandrova GI; Polezhaev FI; Lonskaya NI
Vaccine; 1988 Feb; 6(1):25-8. PubMed ID: 3354254
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine.
Belshe RB; Gruber WC; Mendelman PM; Cho I; Reisinger K; Block SL; Wittes J; Iacuzio D; Piedra P; Treanor J; King J; Kotloff K; Bernstein DI; Hayden FG; Zangwill K; Yan L; Wolff M
J Pediatr; 2000 Feb; 136(2):168-75. PubMed ID: 10657821
[TBL] [Abstract][Full Text] [Related]
17. [Molecular genetic analysis of a cold-adapted donor attenuation strain for a pediatric liver influenza vaccine, of recombinants based on it and of isolates from vaccinated children].
Gendon IuZ; Klimov AI; Lisovskaia KV; Aleksandrova GI; Medvedeva TI
Vopr Virusol; 1984; 29(1):22-8. PubMed ID: 6710977
[TBL] [Abstract][Full Text] [Related]
18. Use of live cold-adapted influenza A H1N1 and H3N2 virus vaccines in seropositive adults.
Treanor JJ; Roth FK; Betts RF
J Clin Microbiol; 1990 Mar; 28(3):596-9. PubMed ID: 2182673
[TBL] [Abstract][Full Text] [Related]
19. A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease.
Edwards KM; Dupont WD; Westrich MK; Plummer WD; Palmer PS; Wright PF
J Infect Dis; 1994 Jan; 169(1):68-76. PubMed ID: 8277200
[TBL] [Abstract][Full Text] [Related]
20. Comparison of live, attenuated H1N1 and H3N2 cold-adapted and avian-human influenza A reassortant viruses and inactivated virus vaccine in adults.
Sears SD; Clements ML; Betts RF; Maassab HF; Murphy BR; Snyder MH
J Infect Dis; 1988 Dec; 158(6):1209-19. PubMed ID: 3198936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
